SAINT: A Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission

ISGlobal researcher Carlos Chaccour presents the main findings of the SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) as principal investigator. For this pilot trial, it was proposed to test the potential of ivermectin to reduce the transmission of the new coronavirus SARS-CoV-2.